Normalization of hepatic ChREBP activity does not protect against liver disease progression in a mouse model for Glycogen Storage Disease type Ia

Martijn G S Rutten, Yu Lei, Joanne H Hoogerland, Vincent W Bloks, Hong Yang, Trijnie Bos, Kishore A Krishnamurthy, Aycha Bleeker, Mirjam H Koster, Rachel E Thomas, Justina C Wolters, Hilda van den Bos, Gilles Mithieux, Fabienne Rajas, Adil Mardinoglu, Diana C J Spierings, Alain de Bruin, Bart van de Sluis, Maaike H Oosterveer*

*Corresponding author for this work

    Research output: Contribution to journal › Article › Academic › peer-review

    66 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'Normalization of hepatic ChREBP activity does not protect against liver disease progression in a mouse model for Glycogen Storage Disease type Ia'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science

    Biochemistry, Genetics and Molecular Biology

    Keyphrases